PTC THERAPEUTICS, INC. — Director's Dealing 2015

Mar 13, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2015-03-13

Reporting Person: Spiegel Robert J. (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-13	Common Stock	S	1028	$75.10	Disposed	3241	Direct
2015-03-13	Common Stock	S	2	$75.95	Disposed	3239	Direct

Footnotes

F1: The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on August 20, 2014 for the primary purpose of covering tax obligations associated with a restricted stock vesting event.

F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $74.92 to $75.89 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.